Company Annexin Pharmaceuticals AB (publ) Nasdaq Stockholm
Equities
Biotechnology & Medical Research
Business Summary
Managers
Managers | Title | Age | Since |
---|---|---|---|
Anna Frostegård
FOU | Founder | 51 | 01/14/01 |
Chief Executive Officer | 63 | 01/18/01 | |
Director of Finance/CFO | 53 | 11/23/11 | |
Susan Suchdev
COO | Chief Operating Officer | 52 | - |
Alain Thibault
PRN | Corporate Officer/Principal | - | 18/23/18 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Uli Alf Hacksell
CHM | Chairman | 74 | 01/21/01 |
Mårten Österlund
BRD | Director/Board Member | 67 | 01/21/01 |
Chief Executive Officer | 63 | 01/18/01 | |
Director/Board Member | 48 | 01/17/01 | |
Director/Board Member | 65 | 01/16/01 | |
Director/Board Member | 66 | 01/17/01 | |
Director/Board Member | 71 | - | |
Anthon Jahreskog
BRD | Director/Board Member | 44 | 01/22/01 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 526,807,199 | 256,124,467 ( 48.62 %) | 0 | 48.62 % |
Company contact information
Sector
1st Jan change | Capi. | |
---|---|---|
+18.15% | 124B | |
+18.02% | 112B | |
-12.75% | 22.22B | |
+5.07% | 22.94B | |
-39.94% | 16.87B | |
-9.86% | 17.02B | |
-14.97% | 16.88B | |
+2.80% | 13.63B | |
+27.39% | 11.61B |